Reacción #595410

ord-67c699208da8410d8f1d48914c2defee

Ecuación de reacción

CCOC(=O)N1CCc2c(c3cc(C)ccc3n2CC(O)CNc2cccc(OC)c2)C1
title compound
CCOC(=O)N1CCc2c(c3cc(C)ccc3n2CC(O)CNc2cccc(OC)c2)C1
Ethyl 5-(2-Hydroxy-3-(3-methoxyphenylamino)propyl)-8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate
[Al+3].[H-].[H-].[H-].[H-].[Li+]
LAH
CO
MeOH
COc1cccc(NCC(O)Cn2c3c(c4cc(C)ccc42)CN(C)CC3)c1
desired product
Rendimiento 5.0%
COc1cccc(NCC(O)Cn2c3c(c4cc(C)ccc42)CN(C)CC3)c1
1-(2,8-dimethyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)-3-(3-methoxyphenylamino)propan-2-ol
Rendimiento 5.0%

Disolventes

Condiciones de reacción

Temperatura
0°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Otroto quench the remaining LAH
  2. 2
    workup.WAITafter 45 min
  3. 3
    Otrothe mixture was partitioned between EtOAc/H2O
  4. 4
    OtroThe organic layer was separated
  5. 5
    Extracciónthe aqueous layer was extracted with EtOAc (3×)
  6. 6
    Lavadothe combined organic layers were washed with satd
  7. 7
    Secadoaq. NaCl, dried over Na2SO4
  8. 8
    Filtraciónfiltered
  9. 9
    Concentraciónconcentrated
  10. 10
    OtroThe crude residue was purified by column chromatography (SiO2, 0-20% MeOH/Acetone+1% Et3N)

Procedimiento

Following a literature procedure (Zoidis et al., Bioorg. Med. Chem. 2009, 17, 1534-1541), the title compound of Example 18 (0.015 g, 0.034 mmol) was dissolved in anhydrous THF (0.34 mL) and cooled to 0° C. A solution of LAH (0.10 mL, 1.0 M in THF) was added dropwise, and the reaction was stirred for 2 h at 0° C. MeOH was added to quench the remaining LAH and after 45 min, the mixture was partitioned between EtOAc/H2O. The organic layer was separated and the aqueous layer was extracted with EtOAc (3×), and the combined organic layers were washed with satd. aq. NaCl, dried over Na2SO4, filtered, and concentrated. The crude residue was purified by column chromatography (SiO2, 0-20% MeOH/Acetone+1% Et3N), followed by PTLC (10% MeOH/Acetone+1% Et3N) to afford the desired product (0.6 mg, 5%).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09095572B2uspto-grants-2015_08